Clinical Trials

20 enrolled

Dendritic Cell Sarcoma, Interdigitating

NCT04889716 2026-03-18

CAR-T Followed by Bispecific Antibodies

42 enrolled

Dendritic Cell Sarcoma, Interdigitating

NCT07249905 2026-03-03

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Phase 1/2 Recruiting

180 enrolled

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone, Dendritic Cell Sarcoma, Interdigitating

NCT06014762 2026-02-27

P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

120 enrolled

Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT07121946 2026-02-10

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

42 enrolled

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Dendritic Cell Sarcoma, Interdigitating

NCT06846463 2026-01-23

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

21 enrolled

Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT07288879 2026-01-08

DALY II Japan

31 enrolled

Dendritic Cell Sarcoma, Interdigitating

NCT06220032 2026-01-05

HO170DLBCL

Phase 3 Recruiting

324 enrolled

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

NCT06736613 2025-12-18

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

50 enrolled

Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT05950802 2025-12-08

ODIN

40 enrolled

Dendritic Cell Sarcoma, Interdigitating

NCT07255963 2025-12-01

Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL

29 enrolled

Dendritic Cell Sarcoma, Interdigitating

NCT06712810 2025-10-10

Q702 for the Treatment of Patients With Hematologic Malignancies

DermatologicLymphoidMyeloidOther hematologic neoplasmSarcoma

46 enrolled

Blastic Plasmacytoid Dendritic Cell Neoplasm, Histiocytosis, Langerhans-Cell, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelomonocytic, Chronic, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Erdheim-Chester Disease, Dendritic Cell Sarcoma, Interdigitating, Histiocytic Sarcoma, Primary Myelofibrosis

NCT05940272 2025-10-09

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

Phase NA Recruiting

48 enrolled

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT05857969 2025-07-11

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

LymphoidMyeloidOther hematologic neoplasmSarcoma

65 enrolled

Familial ependymoma, Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT07057765 2025-07-10

Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL

40 enrolled

Dendritic Cell Sarcoma, Interdigitating

NCT06830031 2025-06-13

C402

18 enrolled

Lymphoma, B-Cell, Pyloric Stenosis, Hypertrophic, Dendritic Cell Sarcoma, Interdigitating

NCT05377307 2025-05-13

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

49 enrolled

Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT06891157 2025-03-24

Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes

148 enrolled

Dendritic Cell Sarcoma, Interdigitating

NCT06151080 2025-02-19

Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL

38 enrolled

Lymphoma, Follicular, Dendritic Cell Sarcoma, Interdigitating

NCT06158399 2025-02-19

AZA Combined With RCHOP in P53-mutated DLBCL.

52 enrolled

Dendritic Cell Sarcoma, Interdigitating

NCT06026488 2024-12-19

Real-World Study of DLBCL With Different Genetic Subtypes

10,000 enrolled

Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT05641428 2024-09-23

HOVON161

300 enrolled

Dendritic Cell Sarcoma, Interdigitating

NCT06534762 2024-08-02

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

BreastGastrointestinalHead & NeckLymphoidSarcomaThoracic

260 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Lymphoma, B-Cell, Dendritic Cell Sarcoma, Interdigitating, Triple Negative Breast Neoplasms

NCT06526065 2024-07-29

Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)

500 enrolled

Dendritic Cell Sarcoma, Interdigitating

NCT06287398 2024-07-22

Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL

39 enrolled

Lymphoma, Follicular, Recurrence, Dendritic Cell Sarcoma, Interdigitating

NCT06299553 2024-05-22

Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)

200 enrolled